Test Code/Short Name | Test Description | COMPONENTS | Clinical Category | Sample | Method/Technology | Storage/Temp | Reporting Time | Pre-test Information |
A-005 | ACID PHOSPHATASE, PROSTATIC AND TOTAL | PROSTATE GLAND DISORDERS | 2 mL (0.5 mL min) serum | Spectrophotometry | Next day | |||
A-042 | ALBUMIN, SERUM | LIVER DISORDERS,KIDNEY DISORDERS | 2 mL (0.5 mL min.) serum | BCG | Daily | |||
A-051 | ALBUMIN, FLUID | INFECTIONS | 2 mL (1 mL min.) Body fluid in a sterile container. | BCG | Daily | |||
A-050 | ALLERGY INDIVIDUAL MARKER, ALTERNARIA TENUIS | ALLERGY | 3 mL (2 ml min.) serum . | ImmunoCAP Specific IgE | Daily | |||
B-11 | BILIRUBIN, DIRECT | Liver Disorders | 2 mL (1 mL min.) serum | DPD | Daily | |||
B-12 | BILIRUBIN, TOTAL | Liver Disorders | 2 mL (1 mL min.) serum | DPD | Daily | |||
B-10 | BILIRUBIN TOTAL, DIRECT AND INDIRECT | Liver Disorders | 2 mL (1 mL min.) serum | DPD,Calculated | Daily | |||
B-13 | BLEEDING TIME; BT | Coagulation Disorders | Conducted on patient. | Ivy’s method | Daily | |||
B-14 | BLOOD GROUP (A, B, O) AND RH FACTOR | Hematology | 4 mL (2 mL min.) whole blood EDTA tube | Erythrocyte Magnetized Technology / Tube Agglutination | Daily | |||
B-20 | BUCCAL SMEAR FOR BARR BODIES | GENETIC DISORDERS | Rinse mouth with water. Prepare 4 slides of scrapings from the buccal mucosa, 2 from left and 2 from right cheek. Fix immediately in 95% ethanol for 30 min. Air dry and ship at room temperature. Provide clinical details on test request form | Aceto-orcein stain | Daily | |||
C-43 | CHLORIDE, 24-HOUR URINE | ELECTROLYTE IMBALANCE | 0 mL (5 mL min.) aliquot of 24-hour urine. | Indirect Ion Selective Electrode | Daily | |||
C-44 | CHLORIDE, FLUID | ELECTROLYTE IMBALANCE | 5 mL (2 mL min.) fluid in a sterile container. | Indirect Ion Selective Electrode | Daily | |||
C-45 | CHLORIDE, RANDOM URINE | ELECTROLYTE IMBALANCE | 10 mL (5 mL min.) aliquot of random urine | Indirect Ion Selective Electrode | Daily | |||
C-116 | CHLORIDE, SERUM | ELECTROLYTE IMBALANCE | 2 mL (1 mL min.) serum | Indirect Ion Selective Electrode | Daily | |||
C-47 | CHOLESTEROL, FLUID | Lipid disorders | 2 mL (1 mL min.) fluid in a sterile container | CHO-POD | Daily | |||
C-59 | CLOTTING TIME; CT | COAGULATION DISORDERES | Conducted on patient. | Lee & White | Daily | |||
C-71 | CORTISOL SUPPRESSION TEST BY DEXAMETHASONE, LOW DOSE | ADRENAL GLAND DISORDERS | Administer tablet 1 mg Dexamethasone orally at 11 p.m. at night. Draw 2 mL (1 mL min.) serum from 1 SST at 8 am next morning. | Chemiluminescent Immunoassay | Daily | |||
D-12 | DIABETIC PROFILE | GLUCOSE,FASTING;LIPID PROFILE BASIC;KIDNEY PROFILE;KFT ;GLYCATED HEMOGLOBIN AIC;THYROID STIMULATING HORMONE;URINE EXAMINATION, ROUTINE;URINE MICROALBUMIN/CREATININE RATIO | DIABETES | 2mL (1 mL min.) plasma IN Sodium Fluoride tubes for Glucose AND 3 mL (2 mL min.) serum AND 3 mL (2 mL min.) whole blood in EDTA tube AND 10 mL (5 mL min.) aliquot of first morning urine . 12 hours strict overnight fasting is mandatory. | Spectrophotometry, HPLC, Dipstick | Daily | ||
D-13 | DIABETIC PLUS HEALTH PROFILE | GLUCOSE,FASTING;LIPID PROFILE BASIC;KIDNEY PROFILE;KFT ;GLYCATED HEMOGLOBIN AIC;THYROID STIMULATING HORMONE;URINE EXAMINATION, ROUTINE;URINE MICROALBUMIN/CREATININE RATIO;LFT;PERIPHERAL SMEAR;CBC | DIABETES | 2mL (1 mL min.) plasma IN Sodium Fluoride tubes for Glucose AND 3 mL (2 mL min.) serum AND 3 mL (2 mL min.) whole blood in EDTA tube AND 10 mL (5 mL min.) aliquot of first morning urine . 12 hours strict overnight fasting is mandatory. | Spectrophotometry, HPLC, Dipstick | Daily | ||
D-14 | DIGOXIN | THERAPEUTIC DRUG MONITORING | 2 mL (1 mL min.) serum . Do not use SST gel barrier tubes. Separate serum within 2 hours of collection. . Trough: just before the next dose is due at steady state. Peak : 6–8 hours after dose. | Chemiluminescent Immunoassay | Daily |